Despite valuation worries and sector setbacks, 2025’s startup IPOs delivered decisive wins—multi-bagger VC returns, ...
Organigram stands out for its strong balance sheet and strategic partnership with BTI. Read why OGI is upgraded to Buy and VFF is downgraded to Strong Sell.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback